Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TT-173 topical haemostatic efficacy in total knee arthroplasty
2015-003408-21Phase 2Active
- Sponsor
- Thrombotargets Europe
- Start
- Oct 2015
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, randomised, single-blind trial of TT-173 in Bleeding (2 arms), sponsored by Thrombotargets Europe. Primary endpoint: Incidence and severity of adverse events. Started Oct 2015; status: active.
02
Drugs
TT-173
03
Conditions
Bleeding
Beyond the preview
Go deeper on 2015-003408-21.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2015-003408-21.